Inventor · disambiguated record
Qingsong Liu
Also filed as: LIU QINGSONG
21 granted patents·11 pending applications·171 citations·filing 2009–2025
93Inventor score
Files withPRECEDO PHARMACEUTICALS CO LTD10HEFEI INST PHYSICAL SCI CAS6TARAPEUTICS SCIENCE INC4DANA FARBER CANCER INST INC3SHENZHEN DYU INTELLIGENT MOBILITY TECH CO LTD2
Top patents by PatentIndex Score
32 records- 0194USD997038SElectric bicycleSHENZHEN DYU INTELLIGENT MOBILITY TECH CO LTD·Filed 2021·Granted Aug 29, 2023·23 cites·1 claims
- 0293US8889706B2Soluble mTOR complexes and modulators thereofWHITEHEAD BIOMEDICAL INST·Filed 2012·Granted Nov 18, 2014·31 cites·6 claims
- 0393US8394818B2Soluble mTOR complexes and modulators thereofGRAY NATHANAEL·Filed 2009·Granted Mar 12, 2013·40 cites·31 claims
- 0491US9879003B2Host targeted inhibitors of dengue virus and other virusesHARVARD COLLEGE·Filed 2013·Granted Jan 30, 2018·20 cites·25 claims
- 0590US9814709B2Bruton's tyrosine kinase inhibitorHEFEI INST PHYSICAL SCI CAS·Filed 2015·Granted Nov 14, 2017·16 cites·13 claims
- 0687USD997039SElectric bicycleZHENGZHOU DYU TECH CO LTD·Filed 2021·Granted Aug 29, 2023·15 cites·1 claims
- 0787US10000483B2Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereofDANA FARBER CANCER INST INC·Filed 2013·Granted Jun 19, 2018·18 cites·37 claims
- 0882USD1007375SElectric bicycleSHENZHEN DYU INTELLIGENT MOBILITY TECH CO LTD·Filed 2021·Granted Dec 12, 2023·8 cites·1 claims
- 0976US2025391871A1Modified polyacrylic acid adhesive, carbon-coated aluminum foil and batteryEVE POWER CO LTD·Filed 2025·Application pending·0 cites
- 1058US2024392251A1Culture medium and culture method for lung cancer epithelial cells, and application thereofPRECEDO PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 1157US2024344020A1Culture medium for lung cancer epithelial cells, culture method, and application thereofPRECEDO PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 1256US12219953B2Pressure self-controlled irrigation and pesticide application sprinkler for micro-irrigation systemUNIV JIANGSU·Filed 2022·Granted Feb 11, 2025·0 cites·6 claims
- 1356US2024284713A1Oled display panel and oled display deviceWUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECH CO LTD·Filed 2023·Application pending·0 cites
- 1452US12318398B2MST1 kinase inhibitor and use thereofHEFEI INST PHYSICAL SCI CAS·Filed 2019·Granted Jun 3, 2025·0 cites·7 claims
- 1552US2023091960A1Culture medium for primary cells of esophageal squamous carcinoma, and cultivation method thereforPRECEDO PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 1652US2023235283A1Culture medium for esophageal squamous cell carcinoma epithelial cells, culture method, and application thereofPRECEDO PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 1752US2024418703A1Culture medium for primary ovarian cancer cells, culture method and application thereofPRECEDO PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 1852US2023416221A1Dihydroisoquinolinone and isoindolinone derivatives and uses thereofHEFEI INST PHYSICAL SCI CAS·Filed 2021·Application pending·0 cites
- 1951US2019292178A9Host targeted inhibitors of dengue virus and other virusesDANA FARBER CANCER INST INC·Filed 2018·Application pending·0 cites
- 2048US12404244B2Pan-KIT kinase inhibitor having quinoline structure and application thereofTARAPEUTICS SCIENCE INC·Filed 2018·Granted Sep 2, 2025·0 cites·8 claims
- 2147US10793543B2Selective C-KIT kinase inhibitorPRECEDO PHARMACEUTICALS CO LTD·Filed 2017·Granted Oct 6, 2020·0 cites·8 claims
- 2246US11602534B2Pyrimidine derivative kinase inhibitorsHEFEI INST PHYSICAL SCI CAS·Filed 2017·Granted Mar 14, 2023·0 cites·8 claims
- 2346US2020024271A9Bone marrow on x chromosome kinase (bmx) inhibitors and uses thereofDANA FARBER CANCER INST INC·Filed 2018·Application pending·0 cites
- 2443US10781214B2Kinase inhibitor against wild-type and mutant EGFRPRECEDO PHARMACEUTICALS CO LTD·Filed 2016·Granted Sep 22, 2020·0 cites·11 claims
- 2543US2022389379A1Primary breast epithelial cell culture medium, culture method and use thereofPRECEDO PHARMACEUTICALS CO LTD·Filed 2019·Application pending·0 cites
- 2640US12162876B2Indazole kinase inhibitor and use thereofTARAPEUTICS SCIENCE INC·Filed 2018·Granted Dec 10, 2024·0 cites·13 claims
- 2740US10669238B2Irreversible bruton's tyrosine kinase inhibitorHEFEI INST PHYSICAL SCI CAS·Filed 2016·Granted Jun 2, 2020·0 cites·21 claims
- 2839US12221448B2Selective PI3Kδ inhibitor and use thereofTARAPEUTICS SCIENCE INC·Filed 2018·Granted Feb 11, 2025·0 cites·13 claims
- 2937US10647700B2EZH2 inhibitor and use thereofTARAPEUTICS SCIENCE INC·Filed 2018·Granted May 12, 2020·0 cites·15 claims
- 3036US10975082B2Inhibitor of FLT3 kinase and use thereofPRECEDO PHARMACEUTICALS CO LTD·Filed 2017·Granted Apr 13, 2021·0 cites·14 claims
- 3136US10350210B2EGFR and ALK dual inhibitorPRECEDO PHARMACEUTICALS CO LTD·Filed 2016·Granted Jul 16, 2019·0 cites·18 claims
- 3233US10266535B2Inhibitor of FLT3 kinase and use thereofHEFEI INST PHYSICAL SCI CAS·Filed 2015·Granted Apr 23, 2019·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Qingsong Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →